Sentence examples for proof of bacterial from inspiring English sources

Proof of bacterial growth might usefully be included in future antibiotic strategies to curtail unnecessary prescriptions.

Conversely, cure of CAP under antibiotic therapy may falsely have been considered as proof of bacterial etiology in a considerable proportion of patients who indeed had a non-bacterial etiology.

In a pioneering proof-of-principle bacterial photographing system, a synthetic light-sensitive chimaeric sensor kinase (Cph1 EnvZ) was made in Escherichia coli by fusing the photoreceptor domain of the phytochrome Cph1 protein from cyanobacterium Synechocystis to the intracellular signal transduction domain of the E. coli EnvZ kinase [ 17], yielding a functional sensor chimaera (Cph8).

In the sonication fluid, a multi-resistant staphylococcus epidermidis (MRSE) was detected, also being resistant to rifampicin, as proof of a bacterial growth on the Vancogenx®-spacer.

Comparison of time-to-result data between the fastest currently accepted method (VITEK) and bacterial cell count monitoring are shown in Table 2. Our results clearly demonstrate the proof of principle of bacterial cell count monitoring for antimicrobial susceptibility testing.

Given the proof reading capabilities of bacterial DNA polymerases (estimated to have an error rate of between 10−9 and 10−11 errors per base pair copied [ 38]), the clonally amplified plasmid represents a relatively clonal starting population with a extremely limited diversity.

Years after the proof-of-principle of such bacterial transmission between nematodes has been established (21), very little is known about the factors affecting this process.

A more promising proof of concept visualized bacterial cells by cryoET using a novel cylindrical holder (Palmer and Löwe 2014).

That is an additional proof that the inhibition of bacterial bioluminescence, either natural luminescent bacteria Vibrio fischeri or recombinant luminescent Escherichia coli, is an early indicator for toxicity that reflects the changes in bacterial energy metabolism [ 31] at a stage where viability is not yet affected.

In proof-of-concept studies performed in bacterial E. coli strains grown in culture or the mouse gastrointestinal tract, the approach can prevent the survival of antibiotic resistant variants.

It will be critically important to obtain well-founded proof of containment control over bacterial therapeutics in order to convince government agencies and the public opinion to allow for their use in medicine.